Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye
Completed
The purpose of this study is to assess the safety and efficacy of iontophoretic delivery of dexamethasone phosphate ophthalmic solution using the EyeGate® II Drug Delivery System in patients with dry eye.
Gender:
ALL
Ages:
12 years and above
Trial Updated:
08/27/2010
Locations: Ophthalmic Research Associates, Andover, Massachusetts +1 locations
Conditions: Dry Eye Syndrome
Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma
Completed
Subjects who qualify for participation will receive lenalidomide with or without dexamethasone in 4 week cycles until disease progression is documented or lenalidomide becomes commercially available for the indication of multiple myeloma.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/10/2010
Locations: Dana-Farber Cancer Institute, Boston, Massachusetts
Conditions: Multiple Myeloma